Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin

Citations Over TimeTop 23% of 2007 papers

Abstract

A series of ansa-quinones has been prepared by chemical synthesis, and evaluated by biological techniques. Thus, 19-membered ansa-lactams, simplified analogues of the naturally occurring Hsp90 molecular chaperone inhibitor geldanamycin, were obtained by concise routes, the key steps being the combination of a ring-closing metathesis to give a 17-membered ring followed by Claisen rearrangement to effect ring expansion. The methodology was also used to prepare an "unnatural" 18-membered ring analogue. In ATPase enzyme assays, the synthetic ansa-quinones were weak inhibitors of Hsp90.

Related Papers

• → Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer(2012)166 cited
• → HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis(2005)38 cited
• → The first total synthesis of sequosempervirin A through an orthoester Claisen rearrangement—ring closing metathesis sequence(2007)21 cited
• → 154 POSTER Hsp90 is expressed and represents a novel target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxy- geldanamycin(2008)1 cited
• → Stable disease for four years in metastatic malignant melanoma treated with the heat shock protein inhibitor 17-AAG(2006)